How a Japanese Food Brand Handled a Health Claim Violation on Douyin: China Advertising Case Study
In early 2026, a well-known Japanese functional food brand found itself at the centre of a regulatory
firestorm on Douyin after health claims made for its flagship probiotic matcha powder triggered an
investigation by local market regulators. This case study examines how the company navigated the
enforcement action, the legal framework that governs food advertising in China, and the critical
lessons that every foreign food brand must learn before entering the world’s most regulated
e-commerce market.
1. Background: A Premium Japanese Brand Meets Douyin
Nihon Wellness Co., Ltd. (“Nihon Wellness”) is a mid-sized functional food
manufacturer headquartered in Osaka, Japan. Founded in 2008, the company built a loyal domestic following
with its line of fermented superfood powders, collagen peptides, and probiotic blends. In late 2024,
flush with success in Japan and Southeast Asia, Nihon Wellness set its sights on the Chinese mainland
market—the world’s largest e-commerce economy by transaction value.
The brand’s flagship product for the China launch was Bio-Matcha Pro, a powdered
probiotic matcha blend positioned as a convenient daily wellness supplement. The product combined
organic Japanese matcha green tea with three strains of Lactobacillus probiotics and
inulin fibre. It was sold exclusively through Nihon Wellness’s Douyin flagship store, which
launched in March 2025 with an aggressive content-marketing strategy.
Douyin (the Chinese mainland version of TikTok) is not merely a social platform—it is the
centrepiece of China’s burgeoning social-commerce ecosystem. With over 700 million daily active
users and integrated in-app shopping features, Douyin has become the first port of call for
foreign food and beverage brands entering China. Nihon Wellness hired a Shanghai-based digital
marketing agency, PulseSocial China, to manage its Douyin account, produce short
video content, and coordinate with key opinion leaders (KOLs) for product endorsements.
The early results were promising. Between March and October 2025, Nihon Wellness’s Douyin
flagship store generated approximately RMB 4.8 million (approx. US$660,000) in gross merchandise
value (GMV), with a repeat purchase rate of 21%. The brand’s content library included over
200 short videos and 60 sponsored KOL posts, all of which centred on the product’s health
benefits.
However, it was precisely those health benefit claims that would soon land Nihon Wellness in
serious regulatory trouble.
2. The Violation: Unauthorised Health Claims on Food Products
A review of Nihon Wellness’s Douyin content—both brand-authored videos and KOL
collaborations—reveals a consistent pattern of problematic claims. The most serious
included:
- “Boosts immunity by 3x” — a quantitative immune-function claim with no regulatory approval;
- “Clinically proven to support digestive health” — a health-function claim that suggested disease-prevention efficacy;
- “Helps prevent cold and flu” — an explicit disease-prevention claim, the most prohibited category for general food;
- “Doctor-recommended daily probiotic formula” — an endorsement that implied medical authority without supporting registration.
Under Chinese law, any food product marketed with health-promotion or disease-prevention claims
must obtain “Blue Hat” (蓝帽子) certification—the formal
designation for a bǎo jiàn shí pǐn (保健食品), or health food. Blue Hat products undergo
a rigorous safety and efficacy review by the State Administration for Market Regulation (SAMR),
including human clinical trial data. The application process typically takes 12–24 months and
costs upwards of RMB 200,000–500,000 per SKU, depending on the complexity of the functional
claims sought.
Bio-Matcha Pro was registered and sold as an ordinary prepackaged food
(食品, shí pǐn) under Chinese Food Safety Law. It had never applied for, nor received, Blue Hat
certification. Yet its marketing copy — especially in short-video formats where text overlays
and voiceovers made explicit health promises — clearly crossed the line into territory reserved
exclusively for licensed health foods.
⚠ Regulatory Violation Summary
Laws Breached: Advertising Law of the People’s Republic of China, Article 17 (prohibiting disease-treatment claims in food advertising); Food Safety Law, Articles 73–75 (requiring Blue Hat registration for health-functional claims).
Products Involved: Bio-Matcha Pro Probiotic Matcha Powder (SKU: NW-BMP-2501).
Claim Categories: Disease prevention (“prevents cold and flu”), quantitative immune function (“boosts immunity 3x”), implied medical endorsement (“doctor-recommended”).
The violation was compounded by the fact that KOL content was largely unvetted. PulseSocial China
had provided the influencers with a “key messaging” document that included all four
of the problematic claims, and the KOLs reproduced them in their own words, often amplifying
the language. In several videos, influencers stated that Bio-Matcha Pro “reduces your
chances of getting sick during winter”—a direct disease-prevention claim that is
among the most strictly forbidden categories under China’s Advertising Law.
3. Regulatory Action: The AMR Investigation
In November 2025, the Shanghai Municipal Administration for Market Regulation (AMR)
opened an investigation into Nihon Wellness following a consumer complaint filed through the
national 12315 hotline. The complainant, a Shanghai-based nutrition blogger, had purchased
Bio-Matcha Pro and noticed the discrepancy between the product’s ordinary food registration
number and its advertised health claims.
The AMR investigation proceeded rapidly. By early December 2025, inspectors had:
- Obtained full access to Nihon Wellness’s Douyin shop backend and content library via the platform’s compliance data-sharing mechanism.
- Interviewed the brand’s China country manager and the account director at PulseSocial China.
- Commissioned an independent review of the product’s actual composition to verify whether any ingredients could lawfully support the advertised claims.
- Flagged the case to the Douyin platform compliance team, which immediately placed the product listing under “special observation” status.
In mid-January 2026, AMR issued its formal Administrative Penalty Decision. The key
components of the penalty were as follows:
| Penalty Element | Detail |
|---|---|
| Administrative Fine | RMB 300,000 (approx. US$41,500) |
| Product Delisting | Bio-Matcha Pro removed from Douyin shop; all inventory held pending re-Labelling review |
| Content Removal | All 200+ brand videos and 60 KOL posts removed; platform-level content purge ordered |
| Correction Period | 30-day notice to rectify all violations and submit a compliance action plan |
| Public Notice | Penalty decision published on Shanghai AMR website (public record) |
The fine of RMB 300,000 was within the standard range for first-time food-advertising violations
under Article 17 of the Advertising Law (which carries penalties from RMB 200,000 to RMB 1 million
for general food advertisers, and up to RMB 5 million for aggravating circumstances). The AMR
noted in its decision that Nihon Wellness was a first-time violator and had cooperated with the
investigation, which justified a penalty at the lower end of the scale. Nevertheless, the total
direct financial impact—including fines, lost revenue from the delisting, agency fees,
and legal costs—was estimated by the brand to exceed RMB 1.2 million within the first
two months of the enforcement action.
4. Nihon Wellness’s Response: A Three-Month Remediation
Faced with an escalating crisis, Nihon Wellness’s Osaka headquarters activated its crisis
management protocol within 48 hours of receiving the AMR notice. The company’s response
was notable for its speed, thoroughness, and willingness to engage proactively with Chinese
regulators—a sharp contrast to the defensive posture sometimes adopted by foreign brands
in similar situations.
4.1 Immediate Takedown and Content Purge
Within 72 hours of the penalty notice, Nihon Wellness voluntarily removed all
Douyin content—not only the flagged videos but every piece of brand-authored content on
the platform. This went beyond the AMR’s immediate order and was intended to demonstrate
good faith. The brand also instructed PulseSocial China to terminate all active KOL partnerships
and issue takedown notices to every influencer who had posted about Bio-Matcha Pro. By the end
of the first week, zero Nihon Wellness-branded health-related content remained on Douyin.
4.2 Legal Counsel and Regulatory Engagement
Nihon Wellness retained Zhonglun Law Firm, a top-tier Chinese law firm with a
dedicated food and drug regulatory practice. Zhonglun’s Shanghai office immediately
assembled a team of four lawyers to guide the brand through the remediation process. The legal
team’s first action was to prepare a comprehensive Correction Action Plan
for submission to AMR, which laid out a 90-day timeline for:
- Complete removal of all non-compliant claims from all channels (Douyin, WeChat, Tmall, JD.com);
- Revision of all product packaging, labels, and marketing collateral;
- Implementation of a compliance training programme for all China-based and Osaka-based marketing staff;
- Initiation of the Blue Hat certification application process;
- Engagement of a third-party compliance auditor for a six-month post-remediation monitoring period.
4.3 Retroactive Blue Hat Application
Perhaps the most significant strategic decision was the brand’s commitment to apply for
Blue Hat certification retroactively. Zhonglun Law Firm guided Nihon Wellness through the
pre-submission consultation process with SAMR’s Centre for Health Food Evaluation. The
brand commissioned a Chinese Contract Research Organisation (CRO) to conduct the required
human clinical trial for immune-function and digestive-health claims—a process expected
to take 10–14 months. While the Blue Hat application was a long-term project, the fact
that the brand had formally commenced the process was viewed favourably by AMR as evidence of
genuine corrective intent.
4.4 Compliance Training Programme
In February 2026, Nihon Wellness implemented a mandatory compliance training programme for
all employees involved in China marketing operations. The training, delivered by Zhonglun
partners and a former SAMR official, covered:
- The regulatory distinction between ordinary food (食品), health food (保健食品), and functional food (功能食品) in China;
- Article-by-article walkthrough of the Advertising Law, with emphasis on Articles 17 and 28 (false advertising);
- The Food Safety Law Blue Hat framework (Articles 73–79);
- Douyin’s specific Food and Health Product Advertising Content Guidelines (抖音食品广告内容指引);
- KOL contract clauses requiring pre-vet approval of all health-related content;
- Real-world case studies of foreign brands that faced enforcement actions in China.
Each employee was required to pass a certification exam with a score of at least 85% before being
allowed to work on any China-facing content. The Osaka head of marketing was personally required
to attend the training and pass the exam—a move that sent a strong signal throughout the
organisation about the seriousness of the undertaking.
4.5 Communication Strategy
Nihon Wellness adopted a policy of transparent but measured external communication. A single
statement was issued on the brand’s WeChat official account, acknowledging the regulatory
action, apologising to consumers, and outlining the corrective measures being taken. The brand
did not dispute the AMR’s findings, did not blame PulseSocial China or the KOLs publicly,
and did not attempt to minimise the seriousness of the violation. This approach was deliberately
designed to avoid the “bad faith” designation that can lead to aggravated penalties
under Chinese administrative enforcement practice.
✅ Best Practice Observed
Nihon Wellness’s decision to remove all content beyond the scope of the AMR order, commence Blue Hat certification, and impose a certification exam on senior management were voluntary measures that went well beyond what was legally required. These actions weighed heavily in the AMR’s decision to allow the brand to resume advertising after three months rather than a longer suspension.
5. Resolution: Resumption of Advertising After Three Months
In April 2026, following the conclusion of the 30-day correction period and a subsequent
follow-up inspection by the Shanghai AMR, Nihon Wellness received formal notification that it
was permitted to resume advertising on Douyin and other platforms—subject to strict
conditions:
- Only claims approved by AMR in advance could be used in any marketing materials;
- All advertising copy must be reviewed and signed off by a designated compliance officer at Zhonglun Law Firm before publication;
- Monthly compliance reports must be submitted to AMR for the first six months;
- Any KOL content must include a disclaimer stating that the product is an ordinary food and not a health food or medicine;
- The Blue Hat application must remain active with quarterly progress updates to AMR.
The brand relaunched Bio-Matcha Pro on Douyin in early May 2026 with completely revised marketing
copy. The new claims were limited to factual descriptions of ingredients (“Contains organic
Japanese matcha and three probiotic strains”) and lifestyle positioning (“A convenient
addition to your morning routine”). No health-function or disease-related language appeared
in any content. The product’s price point was maintained, and the brand invested in
high-quality lifestyle and recipe videos that emphasised taste, origin, and convenience rather
than health benefits.
As of July 2026, the brand’s Douyin store had recovered to approximately 65% of its
pre-violation monthly GMV. While the trajectory was positive, the three-month enforced absence
from the platform had allowed competitors—including a domestic Chinese functional tea
brand and a Korean probiotic brand—to capture significant market share. Nihon Wellness
acknowledged internally that the total cost of the violation (fines, legal fees, CRO clinical
trial costs, lost revenue, and agency costs) would likely exceed RMB 3 million before the
end of 2026.
6. Legal Analysis: The Regulatory Framework for Food Advertising in China
The Nihon Wellness case is a textbook illustration of how China’s advertising and food
safety regulatory framework operates in practice. Foreign brands entering China must understand
three interlocking legal regimes that govern what can and cannot be said about a food product.
6.1 Advertising Law, Article 17 — The Core Prohibition
Article 17 of the Advertising Law of the People’s Republic of China
(revised 2018) states: “Advertisements for drugs, medical devices, health foods, and
formula foods for special medical purposes shall not contain assertions or claims regarding
the prevention or treatment of diseases.” While this article is most commonly cited in
cases involving pharmaceutical products, its scope extends to any advertisement that
suggests a food product can prevent, treat, or cure a disease. The “prevents cold and
flu” and “boosts immunity 3x” claims made by Nihon Wellness fell squarely
within this prohibition because they implied a disease-prevention or therapeutic effect for
an ordinary food.
Notably, Article 17 does not merely prohibit explicit disease claims—it also catches
implied claims made through images, metaphors, or endorsements. An influencer saying
“I haven’t been sick once since I started drinking this” is as legally
problematic as a banner stating “prevents illness.”
6.2 Food Safety Law, Articles 73–75 — The Blue Hat Gateway
Articles 73 through 75 of the Food Safety Law establish the regulatory
framework for health foods. Article 73 requires that all health foods be registered with
SAMR before they are produced or marketed. Articles 74 and 75 set out the safety and efficacy
evaluation requirements, including the submission of toxicological studies, functional tests,
and clinical trial data. Only products that have completed this process may carry the Blue Hat
logo and use approved health claims such as “enhances immune function” or
“supports gastrointestinal health.”
The distinction between ordinary food and health food is not merely formal—it determines
the entire regulatory trajectory. Ordinary foods are regulated under the General Food Safety
standard (GB 2762-2022 and related standards) and cannot make health claims of any kind. Health
foods are regulated under a separate, far more stringent regime. Nihon Wellness’s mistake
was attempting to enjoy the marketing benefits of health food status without bearing the
regulatory burden that accompanies it.
6.3 Douyin’s Food Ad Content Guidelines
In addition to national laws, foreign brands must comply with platform-level content policies.
Douyin’s Food and Health Product Advertising Content Guidelines
(published internally to merchants in 2024) explicitly prohibit:
- Any claim that a food product has therapeutic or disease-preventive effects;
- Comparative claims that suggest superiority over other foods in disease management;
- Use of medical terminology (“clinical trial,” “therapeutic,” “cure”) in food advertising;
- Endorsements by individuals presented as medical professionals (doctors, nutritionists) without verifiable credentials and regulatory disclaimers;
- User testimonials that assert specific health outcomes.
Douyin’s compliance enforcement is increasingly automated. The platform uses AI-powered
content scanning that detects prohibited keywords, medical imagery, and claim patterns in both
video audio tracks and on-screen text overlays. In the Nihon Wellness case, the AMR investigation
was augmented by Douyin’s own compliance reports, which had flagged 37 of the brand’s
videos prior to the consumer complaint.
⚠ Important Distinction for Foreign Brands
Under Chinese law, the advertiser (the brand) bears primary responsibility for the content of advertisements—even when that content is created and published by a third-party influencer or agency. Nihon Wellness could not shift liability to PulseSocial China or the KOLs. Brands are expected to exercise “reasonable care” in vetting all content published under their commercial arrangements. A written contract indemnifying the brand is not a defence against regulatory enforcement.
6.4 Penalty Structure Under the Advertising Law
Article 58 of the Advertising Law prescribes penalties for violations of Article 17. For
first-time offenders, the range is RMB 200,000 to RMB 1 million. Repeat violations or
aggravated circumstances (e.g., misleading vulnerable populations, causing actual harm, or
refusing to cooperate with authorities) can escalate to fines of up to RMB 5 million, suspension
of business operations, and in severe cases, criminal liability for responsible individuals.
The RMB 300,000 fine imposed on Nihon Wellness reflected the mitigating factors of first-time
violation, cooperation, and swift remedial action.
7. Lessons for Foreign Food Brands Entering China
The Nihon Wellness case offers at least seven concrete lessons that every foreign food,
beverage, and supplement brand should internalise before launching on Douyin or any other
Chinese social-commerce platform.
📜 Key Lessons & Actionable Recommendations
- 1. Never make disease-prevention claims without Blue Hat certification. The line between “supports wellness” and “prevents disease” is the single most important regulatory boundary in Chinese food advertising. When in doubt, assume the claim requires Blue Hat approval.
- 2. KOL training is not optional—it is a regulatory necessity. Every influencer who mentions your product must be contractually required to submit content for pre-approval and must receive documented training on China’s advertising law boundaries. PulseSocial China’s failure to train KOLs was a proximate cause of the violation.
- 3. Keep a Chinese regulatory law firm on retainer before you launch. Nihon Wellness engaged Zhonglun only after the violation was already discovered. A pre-emptive legal review of the marketing strategy could have identified the problematic claims before they ever appeared on Douyin. The cost of a retainer is a fraction of RMB 300,000 fine plus RMB 1.2 million in associated losses.
- 4. Pre-review all Douyin content with a compliance checklist. Implement a mandatory two-step review process: (a) an internal compliance officer checks every video script and caption against a prohibited-claims list; (b) external legal counsel reviews any content that touches on health, efficacy, or ingredients with functional connotations.
- 5. Understand that platform AI is watching. Douyin’s automated content scanning systems are increasingly sophisticated. Claims that escape human review will be caught by machine learning models trained on regulatory guidelines. Assume everything you post will be reviewed by AI within hours of publication.
- 6. Plan your Blue Hat strategy from day one. If your product has genuine, verifiable health benefits that you intend to communicate in marketing, begin the Blue Hat application process at least 12 months before your China launch. Work with a qualified CRO and a law firm specialising in health food registration.
- 7. Cooperate fully and transparently if an investigation begins. Nihon Wellness’s cooperative posture was the single most important factor in receiving a moderate penalty and being allowed to resume advertising within three months. Attempting to conceal evidence, delay inspections, or shift blame to third parties can result in aggravated penalties, public naming and shaming, and long-term suspension of advertising rights.
8. Conclusion: Turning a Compliance Crisis into a Strategic Reset
The Nihon Wellness case is not a story of failure—it is a story of how a well-managed
foreign brand navigated a serious regulatory crisis in China’s most dynamic e-commerce
environment. The company made an expensive mistake by running before it could walk, attempting
to use health claims as a shortcut to consumer trust without first securing the regulatory
foundation those claims require. But its response—swift, transparent, legally rigorous,
and strategically forward-looking—turned a potential brand-ending disaster into a
manageable (if costly) regulatory episode.
For other foreign food brands eyeing the Chinese market, the lessons are clear. China’s
advertising and food safety regulatory system is not a paper tiger. It is actively enforced by
a sophisticated network of national regulators, provincial AMRs, and platform-level AI content
monitors. The days of making bold health claims on social media and hoping nobody notices are
over—if they ever truly existed. The brands that will succeed in China are those that
invest in compliance infrastructure as a core business function, not as an afterthought.
Nihon Wellness is now on a path to full Blue Hat certification for Bio-Matcha Pro, with a
compliance framework that exceeds what most foreign food brands of its size maintain in China.
In an ironic sense, the regulatory violation that cost the brand millions may well prove to
be the best investment it ever made—because it forced the organisation to build the
compliance muscle that will protect it for years to come in the world’s most exciting
and demanding consumer market.
“In China, compliance is not a cost centre—it is a competitive moat. The brands
that treat regulatory requirements as a strategic input rather than a bureaucratic obstacle
will be the ones that thrive on Douyin, Tmall, and every other platform in between.”
— China Gateway 360, Advertising Compliance Practice Lead
